echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > GUT: Changes in intestinal flora can exacerbate kidney failure in humans and rodents

    GUT: Changes in intestinal flora can exacerbate kidney failure in humans and rodents

    • Last Update: 2020-06-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    BACKGROUND and Purpose: It has been found in animal studies that patients with kidney failure have symptoms caused by uremia toxins, which may be caused by gut microbes

    Therefore, the purpose of this study is to explore the relationship between the composition of the gut microbiome, uremia toxins and the symptoms of kidney failure in human end-stage nephropathy (ESRD)



    method: The researchers collected 223 ESRD patients and 69 healthy control populations of gut microbiome, serum and fecal metabolites, and human phenotypes

    Cubes reveal the link between these data sets and the use of rodent models of chronic kidney disease (CKD) to test the effects of the gut microbiome on toxin accumulation and disease severity



    results: microbes in ESRD patients are closely related to clinical outcomes and encode the functions involved in the synthesis of toxins and secondary bile acids; The microbiome in sterile mice transplanted to kidney damage or in antibiotic-treated rats induces higher serourets to increase the production of seromyuatia, exacerbating renal fibrosis and oxidative stress than the microbiome of the control group

    Nucleobacteria can improve the production of uremia toxins and promote the development of kidney disease to chronic kidney failure

    Probiotic sylobacteria can reduce the abundance of these species, reduce toxin levels and the severity of disease in rats



    conclusion: ESRD patients intestinal flora abnormal, not conducive to clinical metabolism, suggesting that intestinal flora will become a target to reduce the clinical symptoms of uremia patients

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.